Caricamento...

Metabolic Stability Assessment of Larotrectinib Using Liquid Chromatography Tandem Mass Spectrometry

INTRODUCTION: Larotrectinib (VITRAKVI) is an orally potent tropomyosin receptor kinase (Trk) inhibitor that acts by competitive inhibition of all corresponding receptor kinases. It demonstrated a marked response rate (75%) and robust anticancer activity in Trk fusion-positive patients. This response...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Drug Des Devel Ther
Autori principali: Attwa, Mohamed W, Kadi, Adnan A, Darwish, Hany W
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove 2020
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6961173/
https://ncbi.nlm.nih.gov/pubmed/32021096
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S235934
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !